2025-07-24 - Analysis Report
Okay, here's a report summarizing the provided information on Hims & Hers Health Inc (HIMS):

## Hims & Hers Health Inc (HIMS) - Stock Analysis Report

**Hims & Hers Health Inc (HIMS) is a telehealth company focused on providing personalized health and wellness solutions.**

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 177.40%
*   **VOO Cumulative Return:** 65.67%
*   **Absolute Divergence:** 111.7 (HIMS outperforms VOO by this percentage)
*   **Relative Divergence:** 53.0 (HIMS's outperformance is at the 53rd percentile of its historical range relative to VOO).
    *Interpretation:* HIMS has significantly outperformed the S&P 500. The relative divergence suggests the outperformance is above average compared to its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2019-2021  | -46.0% | 51.0%  | -84.0% | -0.0  | 1.6    |
| 2020-2022  | -15.0% | 72.1%  | -17.0% | -0.0  | 1.6    |
| 2021-2023  | -51.0% | 72.1%  | -69.0% | -0.1  | 2.2    |
| 2022-2024  | 127.0% | 78.4%  | 101.0% | -0.1  | 6.1    |
| 2023-2025  | 172.0% | 78.4%  | 123.0% | -0.1  | 12.5   |

*Analysis:*

*   The CAGR (Compound Annual Growth Rate) shows volatile performance over different periods, with significant negative returns in earlier periods and strong positive returns more recently.
*   MDD (Maximum Drawdown) indicates substantial risk with high drawdowns in all periods.
*   Alpha is highly variable, reflecting periods of significant underperformance followed by strong outperformance.
*   Beta is consistently negative, suggesting a slight inverse correlation with the market. However, the values are close to zero, indicating a very weak relationship.
*   Market capitalization has grown significantly, indicating company expansion.

### 2. Recent Stock Price Movement

*   **Current Price:** 50.01
*   **Last Market Data:** {'price': 55.935, 'previousClose': 50.01, 'change': 11.85}
*   **5-Day Moving Average:** 49.97
*   **20-Day Moving Average:** 48.71
*   **60-Day Moving Average:** 51.25

*Analysis:* The price is above both its 5-day and 20-day moving averages, suggesting a short-term upward trend. However, it's still below the 60-day moving average. The `Last-market` data shows a significant price jump (11.85% change), indicating recent positive momentum.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 54.62 (Neutral)
*   **PPO:** 0.115
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** -1.3 (Indicates short-term decrease)
*   **Expected Return:** -16.5% (Long-term underperformance vs. S&P 500)

*Analysis:*

*   The MRI indicates low market risk.
*   The RSI suggests neutral momentum.
*   The negative change in relative divergence suggests a recent short-term pullback.
*   Despite the recent positive price movement, the long-term expected return is negative, suggesting potential underperformance compared to the S&P 500 if investing for over 2 years.
*   Hybrid Signal suggests that it is reasonable to have some shares

### 4. Recent News & Significant Events

*   **[2025-07-22]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-24]:** Analyst discussions on performance, industry trends, and global economic factors.
*   **[2025-07-20]:** Stock volatility due to recent news, earnings reports, or executive actions.
*   **[2025-07-23]:** Market expert advice to monitor recent news and company announcements.

*Analysis:* These news snippets suggest that HIMS is experiencing significant events and increased attention. Investors should closely monitor company announcements and news for potential impacts.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-05-05 | 0.22  | 0.59 B$    |
| 2024-11-04 | 0.35  | 0.40 B$    |
| 2024-08-05 | 0.06  | 0.32 B$    |
| 2024-05-06 | 0.05  | 0.28 B$    |
| 2025-05-05 | 0.05  | 0.28 B$    |

*Analysis:* EPS and revenue have generally been increasing over the past few quarters, indicating positive financial performance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.59B  | 73.50%        |
| 2024-12-31   | $0.48B  | 76.81%        |
| 2024-09-30   | $0.40B  | 79.16%        |
| 2024-06-30   | $0.32B  | 81.30%        |
| 2024-03-31   | $0.28B  | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE     |
|--------------|---------|---------|
| 2025-03-31   | $0.55B  | 9.01%   |
| 2024-12-31   | $0.48B  | 5.46%   |
| 2024-09-30   | $0.44B  | 17.18%  |
| 2024-06-30   | $0.36B  | 3.67%   |
| 2024-03-31   | $0.34B  | 3.23%   |

*Analysis:*

*   Revenue has consistently grown, indicating strong business expansion.
*   Profit margins have decreased slightly, which may warrant further investigation to understand the underlying causes.
*   Equity has increased, reflecting improved financial stability.
*   ROE (Return on Equity) is variable, indicating fluctuations in profitability relative to equity.

### 7. Summary

Hims & Hers Health Inc (HIMS) has shown strong recent performance, significantly outperforming the S&P 500. The recent positive price surge and increasing revenue are encouraging. However, the negative long-term expected return and the volatility indicated by the Alpha/Beta analysis suggest caution. While the MRI indicates low market risk, investors should closely monitor news and company announcements. The decreasing profit margins need further scrutiny.
